Author
Listed:
- Gabriele Ciceri
(Memorial Sloan Kettering Cancer Center)
- Arianna Baggiolini
(Memorial Sloan Kettering Cancer Center
Bellinzona Institutes of Science (BIOS+)
Faculty of Biomedical Sciences, Università della Svizzera Italiana)
- Hyein S. Cho
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Meghana Kshirsagar
(Memorial Sloan Kettering Cancer Center
Microsoft AI for Good Research)
- Silvia Benito-Kwiecinski
(Memorial Sloan Kettering Cancer Center)
- Ryan M. Walsh
(Memorial Sloan Kettering Cancer Center)
- Kelly A. Aromolaran
(Weill Cornell Medicine)
- Alberto J. Gonzalez-Hernandez
(Weill Cornell Medicine)
- Hermany Munguba
(Weill Cornell Medicine)
- So Yeon Koo
(Memorial Sloan Kettering Cancer Center
Weill Cornell Neuroscience PhD Program)
- Nan Xu
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Kaylin J. Sevilla
(Memorial Sloan Kettering Cancer Center)
- Peter A. Goldstein
(Weill Cornell Medicine)
- Joshua Levitz
(Weill Cornell Medicine)
- Christina S. Leslie
(Memorial Sloan Kettering Cancer Center)
- Richard P. Koche
(Memorial Sloan Kettering Cancer Center)
- Lorenz Studer
(Memorial Sloan Kettering Cancer Center)
Abstract
The pace of human brain development is highly protracted compared with most other species1–7. The maturation of cortical neurons is particularly slow, taking months to years to develop adult functions3–5. Remarkably, such protracted timing is retained in cortical neurons derived from human pluripotent stem cells (hPSCs) during in vitro differentiation or upon transplantation into the mouse brain4,8,9. Those findings suggest the presence of a cell-intrinsic clock setting the pace of neuronal maturation, although the molecular nature of this clock remains unknown. Here we identify an epigenetic developmental programme that sets the timing of human neuronal maturation. First, we developed a hPSC-based approach to synchronize the birth of cortical neurons in vitro which enabled us to define an atlas of morphological, functional and molecular maturation. We observed a slow unfolding of maturation programmes, limited by the retention of specific epigenetic factors. Loss of function of several of those factors in cortical neurons enables precocious maturation. Transient inhibition of EZH2, EHMT1 and EHMT2 or DOT1L, at progenitor stage primes newly born neurons to rapidly acquire mature properties upon differentiation. Thus our findings reveal that the rate at which human neurons mature is set well before neurogenesis through the establishment of an epigenetic barrier in progenitor cells. Mechanistically, this barrier holds transcriptional maturation programmes in a poised state that is gradually released to ensure the prolonged timeline of human cortical neuron maturation.
Suggested Citation
Gabriele Ciceri & Arianna Baggiolini & Hyein S. Cho & Meghana Kshirsagar & Silvia Benito-Kwiecinski & Ryan M. Walsh & Kelly A. Aromolaran & Alberto J. Gonzalez-Hernandez & Hermany Munguba & So Yeon Ko, 2024.
"An epigenetic barrier sets the timing of human neuronal maturation,"
Nature, Nature, vol. 626(8000), pages 881-890, February.
Handle:
RePEc:nat:nature:v:626:y:2024:i:8000:d:10.1038_s41586-023-06984-8
DOI: 10.1038/s41586-023-06984-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Shuyao Zhang & Yuhua Xiao & Xinzhi Mo & Xu Chen & Jiawei Zhong & Zheyao Chen & Xu Liu & Yuanhui Qiu & Wangxuan Dai & Jia Chen & Xishan Jin & Guoping Fan & Youjin Hu, 2024.
"Simultaneous profiling of RNA isoforms and chromatin accessibility of single cells of human retinal organoids,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Panagiotis Douvaras & Diego F. Buenaventura & Bruce Sun & Ashley Lepack & Elizabeth Baker & Elizabeth Simpson & Mark Ebel & Gregory Lallos & Deven LoSchiavo & Nicholas Stitt & Nathaniel Adams & Conor , 2024.
"Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses,"
Nature Communications, Nature, vol. 15(1), pages 1-21, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:626:y:2024:i:8000:d:10.1038_s41586-023-06984-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.